About Rama SmartSearch
RamaOnHealthcare brings signal to noise to keep you up-to-date with the latest healthcare industry news. We continuously refine our search algorithm to help you quickly and easily find the most relevant and human-vetted content from the best sources and authors.
Smart Topics: Rama SmartSearch identifies popular industry keywords as "Smart Topics" and searches article titles for related industry keywords.
You may simply combine keywords to narrow search results. Alternatively, you may use the "AND" operator to also combine keywords.
You may use the "OR" operator to broaden search results to match one or more keywords. Alternatively, you may use the "|" operator to also broaden search results.
You may use quotes to find exact matches, where the keywords are matched in order.
You may use the dash operator to exclude keywords and quoted exact matches from search results.
Clinical Trials Arena January 14, 2026
Amgen is hoping to gain a slice of the obesity market with MariTide, which it claims has a differentiated profile to other approved incretin therapies.
Amgen’s obesity and type 2 diabetes (T2D) hopeful, MariTide (maridebart cafraglutide), has demonstrated its once-quarterly dosing potential in a mid-stage trial, CEO, Robert Bradshaw said.
At a presentation during the first day of...
